5-Lipoxygenase as a putative mechanism of NSAID-related psychiatric adverse events.
Manev
Radmila
R
Manev
Hari
H
D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced* / Q000201:enzymology*; D051379:Mice; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D001094:Arachidonate 5-Lipoxygenase
Arthritis Rheum. 2004 Dec;50(12):3925-33
15593193
Restor Neurol Neurosci. 2002;20(1-2):15-20
12237493
Drugs. 2004;64(23):2619-27
15537366
N Engl J Med. 2004 Jan 1;350(1):29-37
14702425
Nat Genet. 2004 Mar;36(3):233-9
14770184
Crit Rev Neurobiol. 2004;16(1-2):181-6
15581413